The university's scientists have received a $28.5 million award from the Advanced Research Projects Agency for Health to develop a transplantable 3D-printed liver patch. The initiative ...
Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma by designing a study that considered the existing literature ...
ATTR program on hold amid safety risks; HAE therapy faces tough rivals and small market. Read more analysis here.
Organ transplants are a "never-ending tragedy," with referrals steadily going up while the number of organs available remains ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
There are now no new cars in the United States that retail for less than $20,000, as companies exclusively target wealthier ...
The agent, known as AGCL powder, was developed through a cross-disciplinary collaboration between materials science and biological engineering, with input from an active-duty South Korean Army ...
Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog ...
Luma, the a16z-backed AI video and 3D model company, released a new model called Ray3 Modify that allows users to modify existing footage by providing character reference images that preserve the ...
Human periportal assembloid, showcasing the three key cell types of the liver: portal fibroblasts (magenta), cholangiocytes (green), and hepatocyte nuclei (blue). All cell borders are delineated in ...
As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease and resulting liver scarring or cirrhosis also are rising. Patients are ...
Founded by Flagship Pioneering in 2019, Cellarity seeks to embrace biology’s complexity, as diseases are often not driven by a single target, but emerge from a cascade of cellular interactions that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results